浙江圣兆药物科技股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
3
NMPA:3
Drug Approvals
Risperidone for Depot Suspension
- Product Name
- 注射用利培酮微球
- Approval Number
- 国药准字H20253406
- Approval Date
- Feb 20, 2025
NMPA
Risperidone for Depot Suspension
- Product Name
- 注射用利培酮微球
- Approval Number
- 国药准字H20253407
- Approval Date
- Feb 20, 2025
NMPA
Doxorubicin Hydrochloride Liposome Injection
- Product Name
- 盐酸多柔比星脂质体注射液
- Approval Number
- 国药准字H20234166
- Approval Date
- Sep 12, 2023
NMPA
Clinical Trials
No trials found
News
No news found